Login
Search
Search
0 Dates
2025
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
CPC 2025
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Clinical Profiling on Clustering TAVI Patients: Multivariate Analysis of Risk Factors, Clinical Presentation, and Outcome Association
Session:
SESSÃO DE POSTERS 05 - TAVI 1
Speaker:
Antonio Maria Rocha de Almeida
Congress:
CPC 2025
Topic:
H. Interventional Cardiology and Cardiovascular Surgery
Theme:
25. Interventional Cardiology
Subtheme:
25.3 Non-coronary Cardiac Intervention
Session Type:
Cartazes
FP Number:
---
Authors:
António Maria Rocha De Almeida; Rita Louro; Marta Paralta Figueiredo; Rafael Viana; Renato Fernandes; Angela Bento; David Neves; Diogo Brás; Kisa Congo; Manuel Trinca; Alvaro Laranjeira Santos; Lino Patrício
Abstract
<p style="text-align:justify"><strong>Introduction</strong><br /> Despite advances in transcatheter aortic valve implantation (TAVI), patient outcomes remain variable due to the complex interplay of multiple risk factors. Although these factors are well-established predictors, the combined effect of their interactions on clinical outcomes remains challenging to predict. This study aims to stratify TAVI patients according to clinical and risk factor variables, identify distinct risk profile clusters, and examine their association with outcomes.</p> <p style="text-align:justify"><strong>Methods</strong><br /> A retrospective analysis of 300 patients who underwent TAVI was conducted. A two-step cluster analysis was performed to group patients based on clinical presentation and risk factors. Two clusters were identified: Cluster 1 and Cluster 2. The primary endpoint included death at 30 days, stroke, and hospital readmission within one year. Baseline characteristics, procedural variables, and outcomes were compared between clusters.</p> <p style="text-align:justify"><strong>Results</strong><br /> Among 300 TAVI patients, Cluster 1 (n=182) and Cluster 2 (n=32) exhibited similar age and gender distribution, with a mean age of 82±5 and 83±5 years (p=0.6) and females in 54% and 50% (p=0.7), respectively. Comorbidities such as diabetes, chronic kidney disease, and atrial fibrillation were comparable between groups (table 1). Yet, Cluster 1 had a higher prevalence of severe symptoms (NYHA class > 2 in 52% vs. 25%, p=0,005), previous hospitalization for aortic stenosis (28% vs. 3%, p=0.03), and significant mitral regurgitation (30% vs. 12%, p=0,05). Cluster 1 also exhibited a shorter waiting period (48 [24-72] vs. 93 [47-139], p=0,03), potentially reflecting prioritization based on disease presentation severity.</p> <p style="text-align:justify">Cluster 1 was associated with significantly better outcomes despite a higher symptomatic burden. Outcome analysis revealed that Cluster 2 was associated with worse outcomes, including higher 30-day and 1-year mortalities (12% vs. 2%, p<0.001 and 29% vs. 7%, p<0.001) and stroke (6% vs. 0.5%, p<0.01). Hospital readmission rates were also significantly higher in Cluster 2 (16% vs 0.5%, p<0.001). Symptomatic burden with hospitalization may result in an earlier TAVI, as a shorter waiting time is associated with better outcomes.</p> <p style="text-align:justify"><strong>Conclusion</strong><br /> Multivariate clustering of clinical presentation and risk factors successfully identified two distinct clusters of profiles with divergent TAVI outcomes. Notably, despite having more symptomatic disease (as indicated by a higher NYHA class) and a history of hospitalization, patients were associated with better outcomes. The shorter waiting period highlights the potential benefit of earlier intervention for more symptomatic patients. In contrast, Cluster 2 patients experienced higher mortality, stroke, and hospital readmission rates, possibly reflecting the detrimental impact of delays. Earlier prioritization of symptomatic patients for TAVI could significantly improve clinical outcomes.</p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site